Primary malignant lymphoma of the brain: Demonstration of frequent p16 and p15 gene deletions

Japanese Journal of Cancer Research

Volumn 87, Issue 7, 1996, Pages 691-695

  Kumanishi, Toshiro ^a   Zhang, Shujing ^a   Ichikawa, Tomio ^a   Endo, Sumio ^a   Washiyama, Kazuo ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Brain tumor; CDK inhibitor gene; Lymphoma; P16 gene deletion; Tumor suppressor gene

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; MUTATION RATE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 0029746251     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00279.x     Document Type: Article

References (32)

1. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. III, Johnson, B. E. and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
2. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756 (1994).
3. Serrano, M., Hannon, G. J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707 (1993).
4. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261 (1994).
5. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952 (1994).
6. Lo, K.-W., Huang, D. P. and Lau, K.-M. p16 gene alter-ations in nasopharyngeal carcinoma. Cancer Res., 55, 2039-2043 (1995).
7. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
8. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res., 55, 1436-1440 (1995).
9. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J. and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8, 27-32 (1994).
10. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W. and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
11. Gomi, A., Sakai, R., Ogawa, S., Shinoda, S., Hirai, H. and Masuzawa, T. Frequent loss of the cyclin-dependent kinase-4 inhibitor gene in human gliomas. Jpn. J. Cancer Res., 86, 342-346 (1995).
12. Giani, C. and Finocchiaro, G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res., 54, 6338-6339 (1994).
13. Schmidt, E. E., Ichimura, K., Reifenberger, G. and Collins, V. P. CDKN2(p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54, 6321-6324 (1994).
14. Russell, D. S. and Rubinstein, L. J. "Pathology of the Tumours of the Nervous System," 5th Ed., rev. L. J. Rubinstein, pp.590-638 (1989). Edward Arnold, London, Melbourne, Auckland.
15. Hayakawa, T., Takakura, K., Abe, H., Yoshimoto, T., Tanaka, R., Sugita, K., Kikuchi, H., Uozumi, T., Hori, T., Fukui, H., Ushio, Y., Nomura, K., Matsutani, M., Mohri, N., Kumanishi, T., Aozasa, K. and Nagashima, K. Primary central nervous system lymphoma in Japan - A retrospective, co-operative study by CNS-Lymphoma Study Group in Japan. J. Neuro-Oncol., 19, 197-215 (1994).
16. Kumanishi, T., Washiyama, K., Nishiyama, A., Abe, S., Saito, T. and Ichikawa, T. Primary malignant lymphoma of the brain: demonstration of immunoglobulin gene rearrangements in four cases by the Southern blot hybridization technique. Acta Neuropathol., 79, 23-26 (1989).
17. Suci, T., Tajima, K., Nanba, K., Wakasa, H., Mikata, A., Kikuchi, M., Mori, S., Watanabe, S., Mohri, N., Shamoto, M., Harigaya, K., Itagaki, T., Matsuda, M., Kirino, Y., Takagi, K. and Fukunaga, S. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma - A proposal of a new type. Acta Pathol. Jpn., 29, 755-776 (1979).
18. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer, 49, 2112-2135 (1982).
19. Blin, N. and Stafford, D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res., 3, 2303-2308 (1976).
20. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503-517 (1975).
21. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y. Frequent somatic mutation of the MTS1/ CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
22. Morii, K., Tanaka, R., Takahashi, Y., Minoshima, S., Fukuyama, R., Shimizu, N. and Kuwano, R. Structure and chromosome assignment of human S100 a and β subunit genes. Biochem. Biophys. Res. Commun., 175, 185-191 (1991).
23. Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879 (1989).
24. Koga, H., Zhang, S.-J., Ichikawa, T., Washiyama, K., Kuroiwa, T., Tanaka, R. and Kumanishi, T. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry. Brain Tumor Pathol., 11, 151-155 (1994).
25. Sanger, F., Nicklen, S. and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74, 5463-5467 (1977).
26. Arap, W., Nishikawa, R., Furnari, F. B., Cavenee, W. K. and Huang, H.-J. S. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res., 55, 1351-1354 (1995).
27. INK4 in human cancer. Proc. Natl. Acad. Sci. USA, 91, 11045-11049 (1994).
28. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692 (1995).
29. ink4A) gene in primary B-cell lymphomas. Blood, 86, 2724-2731 (1995).
30. ink4B in non-Hodgkin's lymphomas. Blood, 86, 1534-1539 (1995).
31. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R. and Hirai, H. Loss of the cyclin-dependent kinase 4-inhibitor (p16;MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86, 1548-1556 (1995).
32. Koduru, P. R. K., Zariwala, M., Soni, M., Gong, J. Z., Xiong, Y. and Broome, J. D. Deletion of cyclin-dependent kinase 4 inhibitor gene p15 and p16 in non-Hodgkin's lymphoma. Blood, 86, 2900-2905 (1995).